Suzhou Hanerxi Medical Device Development Co., Ltd, a specialist in pen syringe technology based in Suzhou, has reportedly secured “hundreds of millions” of renminbi in a Series B financing round. The round was led by Fuzhe Equity Investment Fund and Jiangsu Trautec Medical Technology Co., Ltd., with additional contributions from And Rui Venture Capital and other investors. The funds raised will be directed towards the construction of what is set to become Asia’s largest facility for the production of injection pens and administration devices.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
